Module 3. Infertility: Protocols and Patient Management
|
|
- Gwendoline Stone
- 6 years ago
- Views:
Transcription
1 Module 3 Infertility: Protocols and Patient Management Ann Scalia, BSN, RN, CNOR Manager Clinical Education Specialists Mary Vietzke, BSN, RN Senior Clinical Educational Specialist Walgreens Faculty Ann Scalia, BSN, RN, CNOR Manager Clinical Education Specialists Mary Vietzke, BSN, RN Senior Clinical Educational Specialist Disclosure: Ann Scalia and Mary Vietzke are employees of Walgreens. There will be discussion regarding off label use of medications during this activity. It is the policy of ProCE, Inc. and NASP to ensure balance, independence, objectivity and scientific rigor in all of its continuing education activities. Faculty must disclose to participants the existence of any significant financial interest or any other relationship with the manufacturer of any commercial product(s) discussed in an educational presentation. 1
2 Objectives Discuss recommended appropriate nonpharmacologic and pharmacologic plans to address infertility Identify monitoring parameters for a patient undergoing treatment for infertility Discuss the different commonly used medication protocols used in an ART cycle Infertility Treatments Varies depending on: Evaluation outcomes Day of cycle Goals of treatment 2
3 Surgical Pretreatments Transvaginal cyst removal Rescued corpus luteum Large anovulatory follicle(s) Endometrioma ( Chocolate cyst ) Laparoscopy Fibroids Adhesions Endometriosis Hydrosalpinx Song Xm, et al. Journal of Obstetrics and Gynaecology Research. 2017;43(1): Karasu T, Ola B. Reproductive Surgery in Assisted Conception: Springer; 2015: Menstrual Cycle Follicular Recruitment Selection of Dominant Follicle LH Surge Follicular Phase Luteal Phase Day 1 Day 7 Day 14 Day Day 28 Speroff, Fritz. Clinical Gynecologic Endocrinology and Infertility. 2005:188. Stauss, Barbieri. Yen & Jaffe s Reproductive Endocrinology: physiology, pathophysiology, and clinical management. 2014: Window of Receptivity for implantation 3
4 Non Pharmacologic Treatment Cycles Natural cycle + timed intercourse Natural cycle + Intrauterine insemination (IUI) Non pharmacologic Biological Markers Menstrual cycle Cervical mucus Basal Body Temperature (BBT) Urinary hormones Pasha H, et al. Iranian journal of reproductive medicine. 2013;11(6):495 Martin PL. American journal of obstetrics and gynecology. 2016;46:
5 Luteinizing Hormone (LH) Levels One step urinary kits that measure LH Easy to use at home Used clinically for timing for intercourse or intrauterine inseminations Martin PL. American journal of obstetrics and gynecology. 2016;46:53 62 Intrauterine Insemination Treatment and monitoring is similar to timed intercourse Sperm sample is specially prepared Sperm are introduced into the uterine cavity via a catheter Used to help overcome negative cervical mucus environments or mild male factor Martin PL. American journal of obstetrics and gynecology. 2016;46:
6 Cervical Mucus Changes During Ovulation Phase Beginning Growth Peak End Estrogen causes cervical mucus production Dominant follicle maturation and estrogen production increases The corpus luteum produces progesterone which dries up the mucus and causes the temperature rise This is the after window of receptivity Martin PL. American journal of obstetrics and gynecology. 2016;46:53 62 Non IVF Ovulation Induction and Controlled Ovarian Stimulation (COS) 6
7 Controlled Ovarian Stimulation (COS) Carefully monitored stimulation of ovaries to produce multiple follicles (which contain eggs) First step in IVF process Protocols designed to decrease risk of OHSS Generally involve 3 classes of medications GnRH analogs (agonist or antagonist) FSH or FSH containing LH gonadotropin hcg final maturation of eggs inside the follicle Assisted reproductive technologies: a guide for patients. American Society for Reproductive Medicine Web site. Monitoring Methods Transvaginal Ultrasound Scans Follicular diameter and count Endometrial thickness Hormone Assay Estrogen levels (baseline and during COS) LH levels (baseline) FSH levels (baseline) Progesterone levels (specific days of cycle) Assisted reproductive technologies: a guide for patients. American Society for Reproductive Medicine Web site. 7
8 Follicular Ultrasound Monitoring Follicle growth documentation Results plotted to observe progression of growth Allows for the most accurate assessment for hcg administration Other documentation Early signs of OHSS such as abdominal fluid, ovarian enlargement, too many follicles Ovarian pathology such as endometriomas or other cyst Assisted reproductive technologies: a guide for patients. American Society for Reproductive Medicine Web site. Hormone Assay Baseline done around cycle day 3 Estrogen, (FSH, LH and progesterone levels may also be evaluated) Helps decision of dose and type of gonadotropin Throughout ovarian stimulation Estrogen levels Assess ovarian response Dosage adjustments hcg Administration Based on estrogen levels with ultrasound Assisted reproductive technologies: a guide for patients. American Society for Reproductive Medicine Web site. 8
9 Monitoring for COS Transvaginal Ultrasound Follicle diameter 16 20mm (typical) Follicle count depending on patient Endometrial thickness >7mm Hormone Assay Estrogen (estradiol) levels coincide with follicle diameter and number ASRM. Fertil Steril. 2015;103(6): Protocol Guide Various protocols used Based on patient, type of cycle (non IVF, IVF) and physician preference Monitoring is required Avoid Ovarian Hyperstimulation Syndrome (OHSS) Goal is safe treatment to achieve birth of healthy singleton baby Alper MM, et al. Reproductive biomedicine online
10 Ovarian Reserve Describes a woman s reproductive potential with respect to ovarian follicle number and oocyte quality Adapted from: Speroff. Clinical Gynecologic Endocrinology and Infertility. 8th ed. Response Types Normal Responder Typically follicles Normal ovarian function Good prognosis (but still limited by maternal age) Poor/Low Responder Usually <4 follicles Typically related to ovarian age factor Possible increased chance of poor outcome Hyper/High Responder Typically >20 follicles Some women at higher risk Low and Slow approach La Marca A, et al Human reproduction update. 2013:
11 Oral Contraceptive Pills (OCP) Oral contraceptive pills, may be prescribed to regulate a patient s menstrual cycle In an ART cycle: Used to suppress or downregulate activity in the ovaries in the prestimulation phase Allows manipulation of the patient's cycle to fit into a set schedule (Batching) Combination hormonal OCP Progestin component of a combination pill prevents ovulation by inhibiting gonadotropin secretion of LH; also alters endometrium Estrogenic component suppresses FSH Stauss, Barbieri. Yen & Jaffe s Reproductive Endocrinology: physiology, pathophysiology, and clinical management. 2014: 895. GnRH GnRH Analogs GnRH Agonists Binds to a receptor and exhibits a desired response GnRH Antagonists Binds to a receptor and inhibits another molecule from binding to the receptor, thus inhibiting the desired response Leuprolide Acetate Cetrotide Ganirelix Acetate Prapas Y, et al. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2013;166(1):
12 Downregulation and Flare Effect Downregulation Process of decreasing cells sensitivity to specific hormones Specific drugs turns off ovaries temporarily gaining control over ovarian function Flare Effect Initial "flare up" response (FSH and LH release) from pituitary gland occurs first 3 days of agonist administration Continuing agonist > 3 days temporarily suppresses pituitary gland Prapas Y, et al. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2013;166(1): GnRH Agonist Loss of response to continued stimulation Downregulation of GnRH receptors Uncoupling of GnRH receptors from intracellular signaling mechanisms E 2, P 4 LH, FSH Flare Effect Start Administration Days Prapas Y, et al. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2013;166(1): Follicular Luteal 12
13 GnRH Antagonist E 2, P 4 LH, FSH NO Flare Effect Start Administration Hours Prapas Y, et al. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2013;166(1): Gonadotropins FSH and/or LH injectable medications Two formulations Urinary extracts Recombinant FSH ASRM. Medications for Inducing Ovulation: Patient Information Series: 2012:
14 Human Chorionic Gonadotropin (hcg) Pregnyl Urinary derived Novarel Urinary derived Generic hcg Urinary derived Ovidrel Recombinant technology CHORIONIC GONADOTROPIN [prescribing insert]. Fresenius, Kabi, Lake Zurich, IL February Pregnyl (chorionic gonadotropin for injection) [prescribing information]. Parsippany, NJ: Ferring Pharmaceuticals Inc.; January OVIDREL PreFilled Syringe (choriogonadotropin alfa injection) [prescribing information]. Rockland, MA: EMD Serono, Inc., September NOVAREL (chorionic gonadotropin for injection) [prescribing information]. Parsippany, NJ: Ferring Pharmaceuticals Inc.; September Human Chorionic Gonadotropin (hcg) Referred to as a trigger shot Mimics LH surge for final oocyte (egg) maturation Very time sensitive medication Ovulation occur within hours after injection Egg retrieval is scheduled 36 hours after injection Too soon or too late will negatively impact cycle resulting in cancellation Costello M, et al. Manual of Ovulation Induction & Ovarian Stimulation Protocols. 2016:
15 Leuprolide Trigger Alternative type of trigger that may be ordered by a fertility office if the patient is responding too well to medications May also be referred to as Lupron trigger Pituitary gland is capable of producing an LH surge sufficient for maturation of follicles in response to a Leuprolide trigger as long as premature ovulation was being prevented by the use of an antagonist like Ganirelix or Cetrotide Costello M, et al. Manual of Ovulation Induction & Ovarian Stimulation Protocols. 2016:454. Leuprolide trigger protocol Most common dosages in a prefilled syringe or vial 1 mg (20 units) 2 mg (40 units) 4 mg (80 units) 5mg (100 units) Some physicians in addition may order a small amount of hcg (such as 1000 or 1500 units) along with the Leuprolide injection to reduce the risk of inadequate maturation of follicles and still keep the risk for OHSS low Costello M, et al. Manual of Ovulation Induction & Ovarian Stimulation Protocols. 2016:
16 Endometrial Support: Estrogen May be prescribed for additional support for the uterine lining, embryo implantation and resulting pregnancy Used in IVF cycles, before and after a frozen embryo transfer and in pregnancy Available formulations: Estradiol valerate injection (intramuscular injection) Estradiol tablets (oral and occasional inserted vaginally) Estradiol patch (Estradiol transdermal system) Role of Progesterone Progesterone for luteal phase support of the endometrium is needed in stimulation cycles Used to build up lining of endometrium for successful implantation Administration begins the day of egg retrieval and continues until pregnancy test If pregnancy occurs the patient will continue on progesterone support Stauss, Barbieri. Yen & Jaffe s Reproductive Endocrinology: physiology, pathophysiology, and clinical management. 2014: Lockwood G, Griesinger G et al. Fertil & Steril. 2014;101(1):
17 Non IVF Ovulation Induction / Stimulation Clomiphene Citrate / Letrozole Non IVF Start either Clomiphene Citrate/ Letrozole Days , 5 9 Stimulation 5 Days Menses Follicular Phase LH monitoring Possible hcg injection IUI / intercourse hrs after positive LH kit or hcg injection Luteal Phase Pregnancy test ~14 days after IUI or intercourse Progesterone support Day 1 Day 7 Day 14 Day 28 Al In any H, et al. Manual of Ovulation Induction & Ovarian Stimulation Protocols. 2016:
18 Gonadotropin Protocol Non IVF Start gonadotropin stimulation Cycle Day 3 Gonadotropin Stimulation ~10 Days Menses Follicular Phase hcg injection IUI or intercourse hrs after hcg injection Luteal Phase Pregnancy test ~14 days after IUI or intercourse Progesterone support Day 1 Day 7 Day 14 Day 28 Al In any H, et al. Manual of Ovulation Induction & Ovarian Stimulation Protocols. 2016:260. IVF Cycle Protocol Phases Prestimulation Downregulation Phase Stimulation Phase Supportive Phase Starts with cycle day one of menses Baseline monitoring Ovarian suppression Oral contraceptive pills (OCP) GnRH agonist Baseline monitoring Start of gonadotropin stimulation medications Development of ovarian follicles Control premature LH surge with GnRH analog Periodic monitoring with blood assays and transvaginal ultrasounds for medication adjustments Trigger shot Egg retrieval Sometimes referred to as Luteal Phase Support Focused on uterine environment for embryo(s) Embryo/Blastocyst Transfer Medication support Progesterone Estrogen 18
19 Supportive Phase Embryo transfer The ET procedure is the last one of the IVF process. Critically important to choose the best quality embryo. Either day 2 or 3 after oocyte retrieval Blastocyst transfer Transferred on day 5 of oocyte retrieval. Chance of selecting best quality embryo for chance at pregnancy. eset Freeze all Center preference Option for those with OHSS Banking embryos for future use ASRM. Fertil Steril. 2012;97 (4): Ovarian Stimulation Protocols Most commonly used Long Luteal (GnRH Agonist Downregulation) Oral Contraceptives optional GnRH Antagonist Oral Contraceptives optional Poor/Low responders/advanced Maternal Age (AMA) Microdose Flare GnRH Antagonist Luteal Estradiol Protocol (Estrogen Priming) Mild Stimulation Protocol (Clomiphene Citrate Priming) Hyper/High responders Long Luteal (GnRH Downregulation) 19
20 Long Luteal Protocol Prestimulation Downregulation Phase Stimulation Phase Progesterone Hormone Assay ~Cycle Day 21 Leuprolide Acetate 0.5 (10U) or 1.0 (20U) mg/day Gonadotropin stimulation ~10 Days hcg Leuprolide Acetate Injection 0.25 (5U) or 0.5 (10U) mg/day Menses Day 21 Baseline Monitoring Egg Retrieval 36 hrs after hcg injection Alper MM, et al. Reproductive biomedicine online Costello M, et al. Manual of Ovulation Induction & Ovarian Stimulation Protocols. 2016:454. Fukuda A. Ovarian Stimulation Protocols: Springer; 2016: La Marca A, et al. Human reproduction update. 2013:dmt037 Long Luteal Protocol Using Oral Contraceptive Pills (OCPs) Prestimulation Downregulation Phase Stimulation Phase Start OCPs first week menses minimum of ~14 days Leuprolide Acetate 0.5 (10U) or 1.0 (20U) mg/day Gonadotropin stimulation ~10 Days Leuprolide Acetate 0.25 (5U) or 0.5 (10U) mg/day hcg Menses Start Leuprolide Acetate Overlap OCPs for 3 days Alper MM, et al. Reproductive biomedicine online Costello M, et al. Manual of Ovulation Induction & Ovarian Stimulation Protocols. 2016:454. Fukuda A. Ovarian Stimulation Protocols: Springer; 2016: La Marca A, et al. Human reproduction update. 2013:dmt037 Menses Baseline Monitoring Egg Retrieval 36 hrs after hcg injection 20
21 GnRH Antagonist Protocol Stimulation Phase Start gonadotropin stimulation Cycle Day 3 GnRH Antagonist start when dominant follicle ~12 14 mm Menses Baseline Monitoring GnRH Antagonist continued daily Gonadotropin stimulation ~10 Days ~Stimulation Day 5 First monitoring check hcg Egg Retrieval 36 hrs after hcg injection Alper MM, et al. Reproductive biomedicine online Costello M, et al. Manual of Ovulation Induction & Ovarian Stimulation Protocols. 2016:454. Fukuda A. Ovarian Stimulation Protocols: Springer; 2016: La Marca A, et al. Human reproduction update. 2013:dmt037 GnRH Antagonist Protocol Using OCPs Prestimulation Downregulation Phase Stimulation Phase Start OCPs first week menses ~14 21 days GnRH Antagonist start when dominant follicle ~12 14 mm GnRH Antagonist continued daily Gonadotropin stimulation ~10 Days hcg Menses OCPs Stopped Alper MM, et al. Reproductive biomedicine online Costello M, et al. Manual of Ovulation Induction & Ovarian Stimulation Protocols. 2016:454. Fukuda A. Ovarian Stimulation Protocols: Springer; 2016: La Marca A, et al. Human reproduction update. 2013:dmt037 Menses Baseline Monitoring ~Stimulation Day 5 First monitoring check Egg Retrieval 36 hrs after hcg injection 21
22 Microdose Flare Protocol Prestimulation Downregulation Phase Stimulation Phase Start OCPs first week menses ~14 21 days Start Microdose Leuprolide Acetate 40 mcg or 50 mcg/10 units twice daily after 3 days of no OCPs On third day of microdose Leuprolide acetate Start gonadotropins hcg Menses Alper MM, et al. Reproductive biomedicine online Costello M, et al. Manual of Ovulation Induction & Ovarian Stimulation Protocols. 2016:454. Fukuda A. Ovarian Stimulation Protocols: Springer; 2016: La Marca A, et al. Human reproduction update. 2013:dmt037 Menses Baseline Monitoring OCPs Stopped Egg Retrieval 36 hrs after hcg injection Luteal Estradiol Protocol Prestimulation Downregulation Phase Stimulation Phase Cycle Day 21 Start Estradiol GnRH Antagonist start when dominant follicle mm Estradiol 1mg 2 tablets bid GnRH Antagonist continued daily Gonadotropin Stimulation hcg Menses Menses Stimulation Day 5 First monitoring check Egg Retrieval 36 hrs after hcg injection Alper MM, et al. Reproductive biomedicine online Costello M, et al. Manual of Ovulation Induction & Ovarian Stimulation Protocols. 2016:454. Fukuda A. Ovarian Stimulation Protocols: Springer; 2016: La Marca A, et al. Human reproduction update. 2013:dmt037 Baseline Monitoring 22
23 Mild Stimulation Protocol Stimulation Phase Start either Clomiphene Citrate/ Letrozole Days 3 7 for 5 Days GnRH Antagonist start when dominant follicle ~12 14 mm GnRH Antagonist continued daily with IVF Cycle ONLY Gonadotropin stimulation hcg Menses Baseline Evaluation Cycle Day 3 Day 5 of Gonadotropin First monitoring check Gonadotropin Stimulation Start Check Egg Retrieval 36 hrs after hcg injection Ferraretti AP, et al Mild ovarian stimulation with clomiphene citrate launch is a realistic option for in vitro fertilization. Fertility and sterility. 2015;104(2): Supportive Phase: All Fresh IVF Protocols Supportive Phase hcg Egg Retrieval 36 Hours after hcg Embryo/Blastocyst Transfer 3 6 Days after Retrieval Pregnancy Test ~14 Days after Transfer Progesterone support started day of retrieval Possible Estrogen support started day of retrieval Alper MM, et al. Reproductive biomedicine online Costello M, et al. Manual of Ovulation Induction & Ovarian Stimulation Protocols. 2016:454. Fukuda A. Ovarian Stimulation Protocols: Springer; 2016: La Marca A, et al. Human reproduction update. 2013:dmt037 23
24 Frozen Embryo Transfer Protocol Embryo/Blastocyst Transfer 3 6 Days after Progesterone Start Progesterone Hormone Assay ~Cycle Day 21 Leuprolide Acetate 0.5 (10U) or 1.0 (20U) mg/day Day 15 of Estradiol Start Progesterone Estradiol 1mg 2 tablets bid or sliding scale Leuprolide Acetate 0.25 (5U) or 0.5 (10U) mg/day Menses Day 21 Baseline Monitoring Endometrium Lining & Estradiol Level Monitoring Fukuda A. Ovarian Stimulation Protocols: Springer; 2016: La Marca A, et al. Human reproduction update. 2013:dmt037 In vitro fertilization (IVF) Ovarian stimulation (daily injections of fertility hormones) Retrieval of oocytes/eggs Eggs and partner or donated sperm combined (through IVF) in lab Fresh embryo transfer or freezing of embryos/oocyte ICSI to assist in fertilization 2017 Walgreens Co. All Rights Reserved 24
25 Prevention of Multiple Gestation The goal of any infertility treatment is a healthy SINGLE full term birth Number of embryos transferred impacts multiple gestation rates With non IVF treatments no control over how many eggs will fertilize IVF use of elective single embryo transfer (eset) is increasing Gerris J. Complications and Outcomes of Assisted Reproduction. 2017:33. Review of Objectives Discuss recommended appropriate non pharmacologic and pharmacologic plans to address infertility Thorough evaluation required so the best individualized plans of treatment can be utilized Identify monitoring parameters for a patient undergoing treatment for infertility Blood assay draws and transvaginal ultrasounds are required for all treatment protocols to minimize risk of developing OHSS Discuss the different commonly used medication protocols used in an ART cycle Many different protocols used and each protocol is applied individually to optimize positive outcome potentials 25
26 Thank You References Song Xm, Jiang H, Zhang Wx, Zhou Y, Ni F, Wang Xm. Ultrasound sclerotherapy pretreatment could obtain a similar effect to surgical intervention on improving the outcomes of in vitro fertilization for patients with hydrosalpinx. Journal of Obstetrics and Gynaecology Research. 2017;43(1): Karasu T, Ola B. Endometrioma and Infertility: Principles and Techniques of Management. Reproductive Surgery in Assisted Conception: Springer; 2015: Mastroianni L, Jr., Laberge JL, Rock J. Appraisal of the efficacy of artificial insemination with husband's sperm and evaluation of insemination technics. Fertility and Sterility. 1957;8(3): Speroff L, Fritz MA. Clinical Gynecologic Endocrinology and Infertility. 7th ed. Philadelphia, PA : Lippincott Williams & Wilkins; 2005:1143, Stauss, Barbieri. Yen & Jaffe s Reproductive Endocrinology: physiology, pathophysiology, and clinical management. 2014: Pasha H, Faramarzi M, Esmailzadeh S, Kheirkhah F, Salmalian H. Comparison of pharmacological and nonpharmacological treatment strategies in promotion of infertility selfefficacy scale in infertile women: A randomized controlled trial. Iranian journal of reproductive medicine. 2013;11(6):495 Martin PL. Detection of ovulation by the basal temperature curve with correlating endometrial studies. American journal of obstetrics and gynecology. 2016;46:
27 References Alper MM, Fauser BC. Ovarian stimulation protocols for IVF: is more better than less? Reproductive biomedicine online Costello M, Koch J, Ledger W. Recombinant LH, Recombinant hcg and GnRH Agonist to Trigger Ovulation: A Critical Evaluation. Manual of Ovulation Induction & Ovarian Stimulation Protocols. 2016:454. Fukuda A. Ovarian Stimulation for Poor Responders. Ovarian Stimulation Protocols: Springer; 2016: La Marca A, Sunkara SK. Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice. Human reproduction update. 2013:dmt037. Prapas Y, Petousis S, Dagklis T, et al. GnRH antagonist versus long GnRH agonist protocol in poor IVF responders: a randomized clinical trial. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2013;166(1):43 46 Costello M, Koch J, Ledger W. Recombinant LH, Recombinant hcg and GnRH Agonist to Trigger Ovulation: A Critical Evaluation. Manual of Ovulation Induction & Ovarian Stimulation Protocols. 2016:454. References Al Inany H, El Mazny A. The Efficacy of Clomiphene Citrate in Preventing a Premature LH Surge during Controlled Ovarian Stimulation with Human Menopausal Gonadotropins. Manual of Ovulation Induction & Ovarian Stimulation Protocols. 2016:260. Ferraretti AP, Gianaroli L, Magli MC, Devroey P. Mild ovarian stimulation with clomiphene citrate launch is a realistic option for in vitro fertilization. Fertility and sterility. 2015;104(2): Gerris J. Minimizing Multiple Pregnancy After Assisted Reproductive Technology. Complications and Outcomes of Assisted Reproduction. 2017:33. 27
28 References Medications Fertility medication information: CLOMIPHENE CITRATE. DailyMed Web site d 93d3 1dedd4d Updated March Accessed January 19, Fertility medication information: CRINONE 8%. DailyMed Web site. d521 41c0 b419 48e028f59f15. Updated August Accessed January 19, Fertility medication information: ENDOMETRIN. DailyMed Web site. b349 40cb 9a4b 1af8faa4ec09#section 1. Updated September Accessed January 19, Fertility medication information: FEMARA. DailyMed Web site f 45ac a7dd 1f5c038bf406. Updated January Accessed January 19, Fertility medication information: FOLLISTIM AQ Cartridge. DailyMed Web site. cc7b 48aa 830aa28e1962d871. Updated December Accessed January 16, Fertility medication information: GANIRELIX ACETATE Injection. DailyMed Web site e d 424a59d574b6. Updated March Accessed January 19, References Medications Fertility medication information: GONAL f Multi Dose. DailyMed Web site. e7eb 4981 a5d e8f189. Updated April Accessed January 19, Fertility medication information: GONAL f RFF Redi ject. DailyMed Web site. b e bb28 2ff596ea259c. Accessed January 19, Fertility medication information: LETROZOLE. DailyMed Web site b7d7 5cb4b5cdcf6a#section 1. Updated October Accessed January 19, Fertility medication information: LEUPROLIDE ACETATE. DailyMed Web site a346 bc5e3acbba0b. Updated January 18, Accessed February 10, Fertility medication information: NOVAREL. DailyMed Web site. 9dc3 40d b26e4bdfc8. Updated September Accessed January 19, Fertility medication information: PREGNYL (chorionic gonadotropin for injection USP) 9c7a 4517 a1b6 9362aab0b86c. Merck Sharp & Dohme B.V., a subsidiary of Merck & Co., Inc. Updated January Accessed January 19,
Principles of Ovarian Stimulation
Principles of Ovarian Stimulation Dr Genia Rozen Gynaecologist and Fertility Specialist Royal Women s Hospital and Melbourne IVF Learning objectives Why ovarian stimulation Recap physiology Ovarian cycle
More informationCigna Drug and Biologic Coverage Policy
Cigna Drug and Biologic Coverage Policy Subject Infertility Injectables Table of Contents Coverage Policy... 1 General Background...16 Coding/Billing Information...20 References...20 Effective Date...
More informationI. ART PROCEDURES. A. In Vitro Fertilization (IVF)
DFW Fertility Associates ASSISTED REPRODUCTIVE TECHNOLOGY (ART) Welcome to DFW Fertility Associates/ Presbyterian-Harris Methodist Hospital ARTS program. This document provides an overview of treatment
More informationDrug Therapy Guidelines
Drug Therapy Guidelines Applicable Injectable Fertility Medications: Bravelle, Cetrotide, Follistim AQ, Ganirelix, Gonal-F, human chorionic gonadotropin, leuprolide, Menopur, Novarel, Ovidrel, Pregnyl,
More informationDrug Therapy Guidelines
Drug Therapy Guidelines Applicable Medical Benefit Effective: 8/15/18 Pharmacy- Formulary 1 x Next Review: 6/18 Pharmacy- Formulary 2 x Date of Origin: 7/00 Injectable Fertility Medications: Bravelle,
More informationART Drugs. Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.30.02 Subject: ART Drugs Page: 1 of 7 Last Review Date: September 15, 2017 ART Drugs Description Bravelle
More informationClinical Policy: Infertility Therapy Reference Number: CP.CPA.261 Effective Date: Last Review Date: Line of Business: Medicaid Medi-Cal
Clinical Policy: Reference Number: CP.CPA.261 Effective Date: 11.16.16 Last Review Date: 11.17 Line of Business: Medicaid Medi-Cal Revision Log See Important Reminder at the end of this policy for important
More informationART Drugs. Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.08.02 Subject: ART Drugs Page: 1 of 7 Last Review Date: December 3, 2015 ART Drugs Description Bravelle
More informationNeil Goodman, MD, FACE
Initial Workup of Infertile Couple: Female Neil Goodman, MD, FACE Professor of Medicine Voluntary Faculty University of Miami Miller School of Medicine Scope of Infertility in the United States Affects
More informationInfertility treatment
In the name of God Infertility treatment Treatment options The optimal treatment is one that provide an acceptable success rate, has minimal risk and is costeffective. The treatment options are: 1- Ovulation
More informationCycle Plan Page1 CYCLE PLAN TYPE CYCLE TYPE: Initial Plan Updated Plan Management Team Review Monitoring Review
Cycle Plan Page1 CYCLE PLAN TYPE Initial Plan Updated Plan Management Team Review Monitoring Review CYCLE TYPE: Undecided - diagnostic testing only Natural Cycle Coitus with IUI Ovulation Induction CC
More informationHCG (human chorionic gonadotropin); Novarel Pregnyl (chorionic gonadotropin); Ovidrel (choriogonadotropin alfa)
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.08.09 Subject: HCG Page: 1 of 5 Last Review Date: June 19, 2015 HCG Powder, Novarel, Pregnyl, Ovidrel
More informationThe effect of adding oral oestradiol to progesterone as luteal phase support in ART cycles a randomized controlled study
Clinical research The effect of adding oral oestradiol to progesterone as luteal phase support in ART cycles a randomized controlled study Ashraf Moini 1,2, Shahrzad Zadeh Modarress 3, Elham Amirchaghmaghi
More informationLUTEAL PHASE SUPPORT. Doç. Dr. Nafiye Yılmaz. Zekai Tahir Burak Kadın Sağlığı Eğitim Araştırma Hastanesi
LUTEAL PHASE SUPPORT Doç. Dr. Nafiye Yılmaz Zekai Tahir Burak Kadın Sağlığı Eğitim Araştırma Hastanesi TAJEV, 2014 1 ART & success *Live birth rate 2 Optimal luteal phase Etiology of luteal phase deficiency
More informationCONTROLLED OVARIAN HYPERSTIMULATION AND OOCYTE RETRIEVAL : CLINICAL INPUTS. DR Priyanka Sinha MD OB-GYN MUMBAI, INDIA
CONTROLLED OVARIAN HYPERSTIMULATION AND OOCYTE RETRIEVAL : CLINICAL INPUTS DR Priyanka Sinha MD OB-GYN MUMBAI, INDIA LEARNING OBJECTIVE Introduction Ovarian stimulation protocols Comparison of different
More informationLuteal phase rescue after GnRHa triggering Progesterone and Estradiol
Luteal phase rescue after GnRHa triggering Progesterone and Estradiol L. Engmann University of Connecticut Disclaimer Fertility Speaker Bureau Merck Pharmaceuticals Introduction GnRH agonist is effective
More informationUW MEDICINE PATIENT EDUCATION. In Vitro Fertilization How to prepare and what to expect DRAFT
UW MEDICINE PATIENT EDUCATION In Vitro Fertilization How to prepare and what to expect This handout tells how to prepare for and what to expect when you go through a cycle of in vitro fertilization. It
More informationLOW RESPONDERS. Poor Ovarian Response, Por
LOW RESPONDERS Poor Ovarian Response, Por Patients with a low number of retrieved oocytes despite adequate ovarian stimulation during fertility treatment. Diagnosis Female About Low responders In patients
More informationINDICATIONS OF IVF/ICSI
PROCESS OF IVF/ICSI INDICATIONS OF IVF/ICSI IVF is most clearly indicated when infertility results from one or more causes having no other effective treatment; Tubal disease. In women with blocked fallopian
More informationAchieving Pregnancy: Obesity and Infertility. Jordan Vaughan, MSN, APN, WHNP-BC Women s Health Nurse Practitioner Nashville Fertility Center
Achieving Pregnancy: Obesity and Infertility Jordan Vaughan, MSN, APN, WHNP-BC Women s Health Nurse Practitioner Nashville Fertility Center Disclosures Speakers Bureau EMD Serono Board of Directors Nurse
More informationIn Vitro Fertilization What to expect
Patient Education In Vitro Fertilization What to expect This handout describes how to prepare for and what to expect when you have in vitro fertilization. It provides written information about this process,
More informationIs it the seed or the soil? Arthur Leader, MD, FRCSC
The Physiological Limits of Ovarian Stimulation Is it the seed or the soil? Arthur Leader, MD, FRCSC Objectives 1. To consider how ovarian stimulation protocols work in IVF 2. To review the key events
More informationPuerto Rico Fertility Center
Puerto Rico Fertility Center General Information of the In-Vitro Fertilization Program Dr. Pedro J. Beauchamp First test-tube baby IN PUERTO RICO Dr. Pedro Beauchamp with Adlin Román in his arms. Paseo
More informationCONSENT FORM FOR TREATMENT WITH OVULATION INDUCTION MEDICATIONS AND INTRAUTERINE INSEMINATIONS
CONSENT FORM FOR TREATMENT WITH OVULATION INDUCTION MEDICATIONS AND INTRAUTERINE INSEMINATIONS INSTRUCTIONS: This consent form provides a description of the treatment that you are undertaking. Read the
More informationN. Shirazian, MD. Endocrinologist
N. Shirazian, MD Internist, Endocrinologist Inside the ovary Day 15-28: empty pyfollicle turns into corpus luteum (yellow body) Immature eggs Day 1-13: 13: egg developing inside the growing follicle Day
More informationIn Vitro Fertilization
Patient Education In Vitro Fertilization About the treatment This handout describes how to prepare for and what to expect when you have in vitro fertilization. It provides written information about this
More informationFERTILITY MEDICATION HANDBOOK
FERTILITY MEDICATION HANDBOOK Welcome to Village Fertility Pharmacy! With more than 25 years in the fertility pharmacy business, we understand that starting a family can be a challenging and emotional
More information5/5/2010. Infertility FINANCIAL DISCLOSURE. Infertility Definition. Objectives. Normal Human Fertility. Normal Menstrual Cycle
Infertility FINANCIAL DISCLOSURE I HAVE NO FINANCIAL INTEREST IN ANY OF THE PRODUCTS MENTIONED IN MY PRESENTATION Bryan K. Rone, M.D. University of Kentucky Obstetrics and Gynecology I AM RECEIVING COMPENSATION
More information2017 United HealthCare Services, Inc.
UnitedHealthcare Pharmacy Clinical Pharmacy Programs Program Number 2017 P 1143-4 Program Prior Authorization/Notification Medication Menopur (menotropins) * P&T Approval Date 8/2014, 5/2015, 5/2016, 5/2017
More informationPhases of the Ovarian Cycle
OVARIAN CYCLE An ovary contains many follicles, and each one contains an immature egg called an oocyte. A female is born with as many as 2 million follicles, but the number is reduced to 300,000 to 400,000
More informationAssisted Reproduction. By Dr. Afraa Mahjoob Al-Naddawi
Assisted Reproduction By Dr. Afraa Mahjoob Al-Naddawi Learning Objectives: By the end of this lecture, you will be able to: 1) Define assisted reproductive techniques (ART). 2) List indications for various
More informationIVF Protocols: Hyper & Hypo-Responders, Implantation
IVF Protocols: Hyper & Hypo-Responders, Implantation Midwest Reproductive Symposium June 4-5, 4 2010 Subset : Hyper-Responders Mark R. Bush, MD, FACOG, FACS OBJECTIVE: Important goals for the PCOS patient
More informationApproach to ovulation induction and superovulation in women with a history of infertility. Anatte E. Karmon, MD
Approach to ovulation induction and superovulation in women with a history of infertility Anatte E. Karmon, MD Disclosures- Anatte Karmon, MD No financial relationships to disclose 2 Objectives At the
More informationMilder is better? Advantages and disadvantages of "mild" ovarian stimulation for human in vitro fertilization
Milder is better? Advantages and disadvantages of "mild" ovarian stimulation for human in vitro fertilization Revelli et al. Reproductive Biology and Endocrinology 2011, 9:25 Presenter: R2 孫怡虹 Background
More informationFemale Reproductive System. Lesson 10
Female Reproductive System Lesson 10 Learning Goals 1. What are the five hormones involved in the female reproductive system? 2. Understand the four phases of the menstrual cycle. Human Reproductive System
More informationUnderstanding Infertility, Evaluations, and Treatment Options
Understanding Infertility, Evaluations, and Treatment Options Arlene J. Morales, M.D., F.A.C.O.G. Fertility Specialists Medical Group, Inc. What We Will Cover Introduction What is infertility? Briefly
More informationWOMEN & INFANTS HOSPITAL Providence, RI CONSENT FOR IVF WITH EMBRYO TRANSFER
*40639* 40639 WOMEN & INFANTS HOSPITAL Providence, RI 02905 CONSENT FOR IVF WITH EMBRYO TRANSFER I have requested treatment by the physicians and (Print Patient s name) staff of the Women & Infants Fertility
More informationProgesterone and clinical outcomes
Synchronization of Slowly Developing Embryos Restores Implantation Success Richard T. Scott, Jr, MD, HCLD Clinical and Scientific Director, Reproductive Medicine Associates of New Jersey Professor and
More informationVanessa N. Weitzman, M.D., Lawrence Engmann, M.D., Andrea DiLuigi, M.D., Donald Maier, M.D., John Nulsen, M.D., and Claudio Benadiva, M.D.
Comparison of luteal estradiol patch and gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation versus microdose gonadotropin-releasing hormone agonist protocol
More informationInfertility. Review and Update Clifford C. Hayslip MD Intrauterine Inseminations
Infertility Review and Update Clifford C. Hayslip MD Intrauterine Inseminations Beneficial effects of IUI not consistently documented in studies No deleterious effects on fertility 3-4 cycles of IUI should
More informationFertility assessment and assisted conception
Fertility assessment and assisted conception Dr Geetha Venkat MD FRCOG Director Pulse Learning Women s health 14 September 2016 Disclosure statement Dr Venkat is a director of Harley Street Fertility Clinic.
More informationRecent Developments in Infertility Treatment
Recent Developments in Infertility Treatment John T. Queenan Jr., MD Professor, Dept. Of Ob/Gyn University of Rochester Medical Center Rochester, NY Disclosures I don t have financial interest or other
More informationDr Manuela Toledo - Procedures in ART -
Dr Manuela Toledo - Procedures in ART - Fertility Specialist MBBS FRANZCOG MMed CREI Specialities: IVF & infertility Fertility preservation Consulting Locations East Melbourne Planning a pregnancy - Folic
More informationPatient Information: Patient Name: Date of Birth:
Weill Cornell Medicine Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine Informed Consent for Oocyte (Egg) Cryopreservation Patient Information: Part 1: I have requested to be treated
More informationFertility care for women diagnosed with cancer
Saint Mary s Hospital Department of Reproductive Medicine Information for Patients Fertility care for women diagnosed with cancer Contents Page Overview... 2 Our service... 2 Effects of cancer treatment
More informationIvf day 6 estradiol level
Ivf day 6 estradiol level Search It is also important to measure the estradiol on day 3. Day 2 is fine. The reason its day 3 is 15-20 years ago, the IVF medications were always started on day 3. Day 3
More informationAMERICAN SOCIETY FOR REPRODUCTIVE MEDICINE
AMERICAN SOCIETY FOR REPRODUCTIVE MEDICINE Formerly The American Fertility Society OVULATION DETECTION A Guide for Patients PATIENT INFORMATION SERIES Published by the American Society for Reproductive
More informationAge and Fertility. A Guide for Patients Revised 2012 Copyright 2012 by the American Society for Reproductive Medicine
1 Age and Fertility A Guide for Patients Revised 2012 Copyright 2012 by the American Society for Reproductive Medicine INTRODUCTION Fertility changes with age. Both males and females become fertile in
More informationBiology of fertility control. Higher Human Biology
Biology of fertility control Higher Human Biology Learning Intention Compare fertile periods in females and males What is infertility? Infertility is the inability of a sexually active, non-contracepting
More informationFemale Reproductive Physiology. Dr Raelia Lew CREI, FRANZCOG, PhD, MMed, MBBS Fertility Specialist, Melbourne IVF
Female Reproductive Physiology Dr Raelia Lew CREI, FRANZCOG, PhD, MMed, MBBS Fertility Specialist, Melbourne IVF REFERENCE Lew, R, Natural History of ovarian function including assessment of ovarian reserve
More informationWOMEN & INFANTS HOSPITAL Providence, RI CONSENT FOR IN VITRO FERTILIZATION USING A GESTATIONAL CARRIER (PATIENT/INTENDED PARENTS) 1.
*40675* 40675 MR-838 (9-2017) WOMEN & INFANTS HOSPITAL Providence, RI 02905 CONSENT FOR IN VITRO FERTILIZATION USING A GESTATIONAL CARRIER (PATIENT/INTENDED PARENTS) 1. I, and (Print Patient s name) (Print
More informationWeb Activity: Simulation Structures of the Female Reproductive System
differentiate. The epididymis is a coiled tube found along the outer edge of the testis where the sperm mature. 3. Testosterone is a male sex hormone produced in the interstitial cells of the testes. It
More informationOutline. Male Reproductive System Testes and Sperm Hormonal Regulation
Outline Male Reproductive System Testes and Sperm Hormonal Regulation Female Reproductive System Genital Tract Hormonal Levels Uterine Cycle Fertilization and Pregnancy Control of Reproduction Infertility
More informationOrgalutran 0.25 mg/0.5 ml solution for injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION
1 1. NAME OF THE MEDICINAL PRODUCT 0.25 mg/0.5 ml solution for injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each pre-filled syringe contains 0.25 mg of ganirelix (INN) in 0.5 mg aqueous solution.
More informationInfertility F REQUENTLY A SKED Q UESTIONS. Q: Is infertility a common problem?
Infertility (female factors). In another one third of cases, infertility is due to the man (male factors). The remaining cases are caused by a mixture of male and female factors or by unknown factors.
More informationIn Vitro Fertilization in Clomiphene-Resistant Women with Polycystic Ovary Syndrome
Original Article Effect of Laparoscopic Ovarian Drilling on Outcomes of In Vitro Fertilization in Clomiphene-Resistant Women with Polycystic Ovary Syndrome Maryam Eftekhar, M.D. 1, Razieh Deghani Firoozabadi,
More informationReproductive Endocrinology & Infertility Glossary
Reproductive Endocrinology & Infertility Glossary The following is a glossary of terms you may hear during your association with the University of Mississippi Health Care's reproductive endocrinology and
More informationEmbryo Selection after IVF
Embryo Selection after IVF Embryo Selection after IVF Many of human embryos produced after in vitro fertilization carry abnormal chromosomes. Placing a chromosomally normal embryo (s) into a normal uterus
More informationEndometrial Preparation for Frozen Embryo Transfer (FET) Zitao Liu, MD, PhD New Hope Fertility Center, NY
Endometrial Preparation for Frozen Embryo Transfer (FET) Zitao Liu, MD, PhD New Hope Fertility Center, NY Natural Cycle FET Protocol for endometrial preparation N FET, including modified N FET HRT FET:
More informationArticle Letrozole versus human menopausal gonadotrophin in women undergoing intrauterine insemination
RBMOnline - Vol 13. No 2. 2006 208-212 Reproductive BioMedicine Online; www.rbmonline.com/article/2334 on web 30 May 2006 Article Letrozole versus human menopausal gonadotrophin in women undergoing intrauterine
More informationCONSENT TO TREATMENT WITH ASSISTED REPRODUCTIVE TECHNOLOGIES
Overview Assisted reproductive technology (ART) The Centers for Disease Control and Prevention (CDC) defines ART to include "all fertility treatments in which eggs or embryos are handled. In general, ART
More informationThe Human Menstrual Cycle
The Human Menstrual Cycle Name: The female human s menstrual cycle is broken into two phases: the Follicular Phase and the Luteal Phase. These two phases are separated by an event called ovulation. (1)
More informationHormonal Control of Human Reproduction
Hormonal Control of Human Reproduction Bởi: OpenStaxCollege The human male and female reproductive cycles are controlled by the interaction of hormones from the hypothalamus and anterior pituitary with
More informationInfertility: failure to conceive within one year of unprotected regular sexual intercourse. Primary secondary
Subfertility Infertility: failure to conceive within one year of unprotected regular sexual intercourse. Primary secondary Infertility affects about 15 % of couples. age of the female. Other factors that
More informationChapter 14 The Reproductive System
Biology 12 Name: Reproductive System Per: Date: Chapter 14 The Reproductive System Complete using BC Biology 12, page 436-467 14. 1 Male Reproductive System pages 440-443 1. Distinguish between gametes
More informationCASE 41. What is the pathophysiologic cause of her amenorrhea? Which cells in the ovary secrete estrogen?
CASE 41 A 19-year-old woman presents to her gynecologist with complaints of not having had a period for 6 months. She reports having normal periods since menarche at age 12. She denies sexual activity,
More informationThe legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 22 September 2010
The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 22 September 2010 100 µg/0.5 ml, solution for injection B/1 prefilled syringe + 1 needle (CIP code: 374 590-1) 150
More informationBest practices of ASRM and ESHRE
Best practices of ASRM and ESHRE Late submission Cortina d Ampezzo, Italy 1-3 March 2012 A joint meeting between the American Society for Reproductive Medicine and the European Society of Human Reproduction
More informationNEW PATIENT DATA SHEET Please complete as best you can. It is not necessary to have all information before speaking with a doctor. PATIENT INFORMATION
NEW PATIENT DATA SHEET Please complete as best you can. It is not necessary to have all information before speaking with a doctor. PATIENT INFORMATION PATIENT NAME DOB AGE PARTNER NAME DOB AGE STREET CITY
More informationInformation Booklet. Exploring the causes of infertility and treatment options.
Information Booklet Exploring the causes of infertility and treatment options www.ptafertility.co.za info@ptafertility.co.za +27 12 998 8854 Faith is taking the first step even if you don t see the whole
More informationIVF AND PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY (PGT-A) WHAT THE COMMUNITY PHYSICIAN NEEDS TO KNOW
IVF AND PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY (PGT-A) WHAT THE COMMUNITY PHYSICIAN NEEDS TO KNOW Jon Havelock, MD, FRCSC, FACOG Co-Director - PCRM Disclosure No conflict of interest in relation
More informationArizona Reproductive Medicine Specialists. Assisted Reproductive Technology. Patient Guide
Arizona Reproductive Medicine Specialists Assisted Reproductive Technology Patient Guide Welcome All of us at Arizona Reproductive Medicine Specialists are pleased to welcome you to our program. We know
More informationCONSENT TO TREATMENT WITH ASSISTED REPRODUCTIVE TECHNOLOGIES
Overview Assisted reproductive technology (ART) The Centers for Disease Control and Prevention (CDC) defines ART to include "all fertility treatments in which both eggs and sperm are handled. In general,
More informationFertility Treatment: Do not be Distracted
Fertility Treatment: Do not be Distracted Fertility Treatment: do not be distracted by worthless recommendation Fertility Treatment: Do not be Distracted When contemplating options for fertility treatment
More information1. During the follicular phase of the ovarian cycle, the hypothalamus releases GnRH.
1. During the follicular phase of the ovarian cycle, the hypothalamus releases GnRH. 2. This causes the anterior pituitary to secrete small quantities of FSH and LH. 3. At this time, the follicles in the
More information10.7 The Reproductive Hormones
10.7 The Reproductive Hormones December 10, 2013. Website survey?? QUESTION: Who is more complicated: men or women? The Female Reproductive System ovaries: produce gametes (eggs) produce estrogen (steroid
More informationReproductive System. Testes. Accessory reproductive organs. gametogenesis hormones. Reproductive tract & Glands
Reproductive System Testes gametogenesis hormones Accessory reproductive organs Reproductive tract & Glands transport gametes provide nourishment for gametes Hormonal regulation in men Hypothalamus - puberty
More informationAgonist versus antagonist in ICSI cycles: a randomized trial and cost effectiveness analysis Badrawi A, Zaki S, Al-Inany H, Ramzy A M, Hussein M
Agonist versus antagonist in ICSI cycles: a randomized trial and cost effectiveness analysis Badrawi A, Zaki S, Al-Inany H, Ramzy A M, Hussein M Record Status This is a critical abstract of an economic
More informationREstradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization
REstradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? FTThe Journal of Reproductive
More informationCauses of Infertility and Treatment Options
Causes of Infertility and Treatment Options Dr Mrs.Kiran D. Sekhar Former vice President-FOGSI Former Chairperson- Genetics and Foetal medicine-fogsi Founder and Medical Director-Kiran Infertility centre
More informationFactors influencing serum progesterone level on triggering day in stimulated in vitro fertilization cycles
ORIGINAL ARTICLE pissn 2233-8233 eissn 2233-8241 Clin Exp Reprod Med 2015;42(2):67-71 Factors influencing serum progesterone level on triggering day in stimulated in vitro fertilization cycles Ju Hee Park
More informationBumiputera Sarawak Bumiputera Sabah. Others Foreigner. Had previous natural pregnancy Previous IVF pregnancies. IVF live births.
a. Date of notification: b. Name of reporting site: c.name of doctor in charge: AI : FEMALE PATIENT DETAILS & DEMOGRAPHICS (Instruction: if Mykad is not available, please complete Old IC or other ID document
More informationSTIMULATION AND OVULATION TRIGGERING
STIMULATION AND OVULATION TRIGGERING Professor IOANNIS E. MESSINIS MD, PhD (Aberdeen, UK), FRCOG (UK) Department of Obs/Gynae University of Thessaly Larissa, GREECE DISCLOSURE Nothing to disclose Learning
More informationInfertility Clinical Guideline
Infertility Clinical Guideline Ovarian Stimulation Guideline Purpose: To provide sufficient background regarding various ovarian stimulation protocols for In Vitro Fertilization cycles. Goal: To assist
More informationMODULE 1: OVULATION INDUCTION IN NORMAL RESPONDERS, POOR RESPONDERS, AND HYPERRESPONDERS
MODULE 1: OVULATION INDUCTION IN NORMAL RESPONDERS, POOR RESPONDERS, AND HYPERRESPONDERS Contents OVULATION INDUCTION IN NORMAL RESPONDERS, POOR RESPONDERS, AND HYPERRESPONDERS Ovulation Induction.....................................................................
More informationEVALUATING THE INFERTILE PATIENT-COUPLES. Stephen Thorn, MD
EVALUATING THE INFERTILE PATIENT-COUPLES Stephen Thorn, MD Overview The field of reproductive medicine continues to evolve rapidly by offering newer diagnostic testing and therapeutic options to improve
More informationPartner Name: Patient Signature Partner Signature (If applicable) Date (COS/IUI) Witness Name Witness Signature Date
1. Please place your initials below to indicate which components of controlled ovarian Stimulation (COS) and intrauterine insemination (IUI) treatment you agree to undertake in your upcoming treatment
More informationIntroduction to CRM. Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine - CRM
Introduction to CRM Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine - CRM 1 CRM Locations Upper East Side (Main Office) 1305 York Avenue, 6 th Floor New York, NY 10021 *open 7 days
More information2018 UnitedHealthcare Services, Inc.
UnitedHealthcare Pharmacy Clinical Pharmacy Programs Program Number 2018 P 2149-1 Program Prior Authorization/Medical Necessity Supported By Fertility Solutions Medication Follistim AQ (follitropin beta),
More informationClinical Study Clinical Effects of a Natural Extract of Urinary Human Menopausal Gonadotrophin in Normogonadotropic Infertile Patients
International Reproductive Medicine Volume 2013, Article ID 135258, 4 pages http://dx.doi.org/10.1155/2013/135258 Clinical Study Clinical Effects of a Natural Extract of Urinary Human Menopausal Gonadotrophin
More informationJournal of American Science 2013;9(12) Mohamed Elkadi, Amr Elhelaly, Ahmed Ibrahim, Shereen Abdelaziz
Clomiphene Citrate Alone or Followed by Human Chorionic Gonadotropin In Induction of Ovulation. Mohamed Elkadi, Amr Elhelaly, Ahmed Ibrahim, Shereen Abdelaziz Department of Obstetrics and Gynecology Ain
More informationWHY INVESTIGATE FOR INFERTILITY
WHY INVESTIGATE FOR INFERTILITY Intrauterine Insemination 1 About this booklet This series of booklets has been developed and written with the support of leading fertility clinics across Australia, and
More informationIntroduction to Intrauterine Insemination (IUI) Service
Introduction to Intrauterine Insemination (IUI) Service Assisted Reproductive Technology Unit The Chinese University of Hong Kong Prince of Wales Hospital 2017 Treatment Procedures IUI involves six main
More informationChapter 14 Reproduction Review Assignment
Date: Mark: _/45 Chapter 14 Reproduction Review Assignment Multiple Choice Identify the choice that best completes the statement or answers the question. 1. Use the diagram above to answer the next question.
More informationOocyte Cryopreservation Process, Risk, and Consent
Oocyte Cryopreservation Process, Risk, and Consent While embryos and sperm have been frozen and thawed with good results for many years, eggs have proved much more difficult to manage. Newer egg freezing
More informationFertility 101. About SCRC. A Primary Care Approach to Diagnosing and Treating Infertility. Definition of Infertility. Dr.
Dr. Shahin Ghadir A Primary Care Approach to Diagnosing and Treating Infertility St. Charles Bend Grand Rounds November 30, 2018 I have no conflicts of interest to disclose. + About SCRC State-of-the-art
More informationSchedule of Fees for Private Treatment
Schedule of Fees for Private Treatment Fertility Treatment is personalized to each individual and couple, based on diagnosis and best treatment options. At Fertility Plus, we are mindful of the costs involved
More informationVaginal micronized progesterone versus intramuscular progesterone for luteal support in women undergoing in vitro fertilization embryo transfer
Vaginal micronized progesterone versus intramuscular progesterone for luteal support in women undergoing in vitro fertilization embryo transfer Mohamed F. Mitwally, M.D., H.C.L.D., a Michael P. Diamond,
More informationPatient Overview: Invitro Fertilisation
Patient Overview: Overview IVF stands for in-vitro fertilisation i.e. literally fertilisation in a glass dish. You may also hear the term ART used which stands for Assisted Reproductive Technologies. IVF
More information